GFAP is a marker for astrocytic differentiation and we observed that in GBM primary cultures, R2 immunoreactivity was stronger in the absence of GFAP, and became fainter as long as the GFAP marker became stronger, further supporting the idea that R2 expression is linked to a less differentiated cell phenotype. Here, GFAP is linked to glioblastoma.